A. Yeung

Antibody-directed therapy for human hepatocellular carcinoma.

J. Wands, L. Mohr, C. Aloman, 2004, Gastroenterology.

1083 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that mediates potent anti-tumor activity, cytotoxicity, and expansion of memory CD8+ T cells

H. Sultan, Irene Ni, W. Prior, 2022, Regular and Young Investigator Award Abstracts.

717 Selective activation of CD8+ T cells by a CD8-targeted IL-2 results in enhanced anti-tumor efficacy and safety

T. Schumacher, Irene Ni, K. Moynihan, 2021, Journal for ImmunoTherapy of Cancer.